IU

Ibad Ur Rehman

Active Director Director DIN 11463547
DIN 11463547 First appointment Jan 2026 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Jan 2026
Shareholding value Locked Premium profile

About Ibad Ur Rehman

Ibad Ur Rehman has experience in corporate governance. Holds Director role. Currently with 1 company, including Aidenmark Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 11463547
Primary Designation Director
First Appointment 05 Jan 2026
Oldest Company Age Not Provided

Current companies

Company Designation Appointment Founded Status
Director 05 Jan 2026 2026 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aidenmark Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Ibad Ur Rehman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ibad Ur Rehman

Ibad Ur Rehman has experience in corporate governance. Holds Director role. Currently with 1 company, including Aidenmark Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations.

Ibad Ur Rehman is associated with 1 company as Director.

Ibad Ur Rehman has expertise in General Business.

Ibad Ur Rehman has extensive experience in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available